- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 20/08 - Direct analysis of the library members per se by physical methods, e.g. spectroscopy
Patent holdings for IPC class C40B 20/08
Total number of patents in this class: 67
10-year publication summary
7
|
2
|
3
|
3
|
5
|
1
|
1
|
2
|
0
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20087 |
4 |
Momenta Pharmaceuticals, Inc. | 297 |
4 |
Fuso Pharmaceutical Industries, Ltd. | 123 |
3 |
Massachusetts Institute of Technology | 10110 |
2 |
The General Hospital Corporation | 4771 |
2 |
President and Fellows of Harvard College | 5998 |
2 |
Agency for Science, Technology and Research | 3646 |
2 |
Roche Sequencing Solutions, Inc. | 658 |
2 |
University of Ottawa | 214 |
2 |
Adapsyn Bioscience Inc. | 4 |
2 |
F. Hoffmann-La Roche AG | 7947 |
1 |
Roche Diagnostics GmbH | 2697 |
1 |
Agilent Technologies, Inc. | 2638 |
1 |
Applied Biosystems, LLC | 327 |
1 |
The Trustees of Columbia University in the City of New York | 3589 |
1 |
Abbvie Biotherapeutics Inc. | 71 |
1 |
Arcus Biosciences, Inc. | 140 |
1 |
Arizona Board of Regents Acting for and on Behalf of Arizona State University | 99 |
1 |
Bioinvent International AB | 83 |
1 |
Caprion Pharmaceuticals, Inc. | 11 |
1 |
Other owners | 32 |